Transfer Factor Plus - The Immune System and Cancer

According to Dr. George C Pack, MD, a cancer specialist at Cornell medical School, almost everyone has cancer cells present at times in our bodies. If our immune system is working properly, these cells are killed or reabsorbed by our defense system before they begin to grow and threaten our health. The only real defense against cancer is the immune system.

The Cancer Research Institute was founded in 1953 to foster the science of cancer immunology, which is based on the premise that the body's immune system can be mobilized against cancer. This field, which CRI helped pioneer and develop, has been recognized throughout the world as offering great hope for the ultimate prevention and treatment of human cancer.

The immune response is the body's way of defending itself against foreign substances that invade it to cause infection or disease. The immune system's job is a complicated process that involves the coordinated efforts of several types of white blood cells. Click here to see how the body's immune system kills foreign invaders.

Trials with Transfer factor and Cancers

Darryl See, M.D. conducted the following studies after his initial trial showed the awesome immune boosting qualities of Transfer factor.

The initial results of a groundbreaking independent study using Transfer Factor and Transfer Factor Plus yielded unprecedented results in a study done by the Institute of Longevity Medicine in California, a laboratory recognized for its research and expertise in measuring the ability of ingredients to significantly boost the immune system. Dr See had showed that Transfer Factor Plus increased the NK cell activity 248% above normal immune response without supplementation, or about five times higher than any of the other 196 previously tested products. This is higher than any other drug, vitamin, herb, etc.

In the follow up research, twenty patients, 12 men and 8 women, were selected for this in vivo study. The average age was 49.3. The twenty individuals were each level 3 or level 4 cancer patients. Each patient was basically sent home by his or her oncologist to die. The average life expectancy was 3.7 months. The protocol was to place each patient on 9 capsules per day of Transfer Factor Plus. The patients were given a number of other general nutrients. After eight months, 16 of these individuals were still living and were either in remission, improving or stabilized.

The baseline for natural killer cell function was 6.4. Within 4 weeks the average NK Cell function was increased to 25.7 and in 6 months it increased to 27.6. This represented a 400% increase in NK Cell function. This is an ongoing study. This study has been submitted to a peer reviewed publication.